| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Acer Therapeutics Inc. | CHIEF LEGAL OFFICER AND SECRETARY | Employee Stock Option (right to buy) | 30,000 | 14 Mar 2023 | Direct | ||
| ACHIEVE LIFE SCIENCES, INC. | Director | Stock Option (right to buy) | 4,400 | 31 May 2022 | Direct | ||
| Acer Therapeutics Inc. | CHIEF LEGAL OFFICER AND SECRETARY | Common Stock, $0.0001 par value per share | 0 | 17 Nov 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000089924323020441-joseph-donald-2023-11-17 | Acer Therapeutics Inc. | 17 Nov 2023 | 1 | $0 | 4 | CHIEF LEGAL OFFICER AND SECRETARY | 20 Nov 2023, 17:05 |
| /report/000120919123019327-joseph-donald-2023-03-14 | Acer Therapeutics Inc. | 14 Mar 2023 | 1 | $0 | 4 | Chief Legal Officer and Secy | 16 Mar 2023, 16:41 |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | 31 May 2022 | 1 | $0 | 4 | Director | 01 Jun 2022, 16:11 |
| /report/000120919122003720-joseph-donald-2022-01-14 | Acer Therapeutics Inc. | 14 Jan 2022 | 1 | $0 | 4 | Chief Legal Officer and Secy | 19 Jan 2022, 15:24 |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | 11 May 2021 | 1 | $0 | 4 | Director | 13 May 2021, 16:18 |